| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $486K | -54.3% |
| R&D Expense | $39.4M | +96.7% |
| SG&A Expense | $17.1M | +21.5% |
| Operating Income | -$56.0M | -69.5% |
| Pre-tax Income | -$51.4M | -75.1% |
| Income Tax | $7K | +75.0% |
| Net Income | -$51.4M | -75.1% |
| EPS (Basic) | -$1.67 | -9.9% |
| EPS (Diluted) | -$1.67 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.1M | -43.7% |
| Current Assets | $82.1M | -32.0% |
| Total Assets | $84.3M | -31.8% |
| Current Liabilities | $12.6M | +146.2% |
| Total Liabilities | $14.0M | +48.9% |
| Stockholders' Equity | $70.4M | -38.4% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.1M | -63.1% |
| Investing Cash Flow | -$13.1M | — |
| Financing Cash Flow | $3.2M | -97.5% |
| -9.9% |